Gluconic Acid

Gluconic Acid

SCHEMBL721131

O.O.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Fe+2]

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHESCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9A

The experimentally established mechanism targets of Gluconic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.87
PDE4A P27815 1/20 0.64
L3MBTL1 Q9Y468 1/20 0.50
USP2 O75604 1/20 0.48
SLCO1B1 Q9Y6L6 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
OR51E2 Q9H255 1/20 0.39
KDM4E B2RXH2 2/20 0.37
CYP2C9 P11712 1/20 0.32
TSHR P16473 1/20 0.32
CA4 P22748 2/20 0.31
TOP1 P11387 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Gluconic Acid SCHEMBL473633 1.00 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL1565178 1.00 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL19585112 1.00 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL22442432 1.00 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL7265130 1.00 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL9456606 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL161222 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL35424 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL3768836 0.98 LMNA (0.91) LMNAPDE4AL3MBTL1USP2SLCO1B1
Gluconic Acid SCHEMBL23566696 0.95 LMNA (0.87) LMNAPDE4AL3MBTL1USP2SLCO1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250353748-A1 Three-Dimensional Structured Ferrous Phosphate Pigment with Corrosion Early Warning Capability and Preparation Method Therefor LANXI MAGNESIUM MATERIALS RES INSTITUTE (CN) 2025-11-20 US claimed
CN-119218955-B Three-dimensional structure ferrous phosphate pigment with corrosion early warning capability and preparation method thereof 兰溪市镁材料研究院 2025-04-15 CN claimed
CN-119218955-A Three-dimensional structure ferrous phosphate pigment with corrosion early warning capability and preparation method thereof 兰溪市镁材料研究院 2024-12-31 CN claimed
CN-107854485-A The medical composition and its use of the various trace elements of injection 刘力 2018-03-30 CN claimed
CN-107693539-A The medical composition and its use of various trace elements 刘力 2018-02-16 CN claimed
CN-103340895-B Composition containing various microelements, preparation and preparation method thereof JIANGXI BOYITE TECHNOLOGY CO LTD 2015-02-18 CN claimed
WO-2015020516-A1 IMPROVED POLLEN AND/OR POLLEN SUBSTITUTE COMPRISING BEE FOOD COMPOSITION SUSTAIN B.V. (NL) 2015-02-12 WO claimed
CN-103340895-A Composition containing various microelements, preparation and preparation method thereof JIANGXI BOYITE TECHNOLOGY CO LTD 2013-10-09 CN claimed
US-8491861-B2 Synthetic process for preparation of high surface area electroactive compounds for battery applications ELTRON RESEARCH, INC. (US) 2013-07-23 US claimed
US-20130153821-A1 SYNTHETIC PROCESS FOR PREPARATION OF HIGH SURFACE AREA ELECTROACTIVE COMPOUNDS FOR BATTERY APPLICATIONS ELTRON RESEARCH, INC. (US) 2013-06-20 US claimed
WO-2008060701-A9 SYNTHETIC PROCESS FOR PREPARATION OF HIGH SURFACE AREA ELECTROACTIVE COMPOUNDS FOR BATTERY APPLICATIONS ELTRON RES & DEV INC (US) 2008-09-25 WO claimed
WO-2008060701-A2 SYNTHETIC PROCESS FOR PREPARATION OF HIGH SURFACE AREA ELECTROACTIVE COMPOUNDS FOR BATTERY APPLICATIONS ELTRON RESEARCH & DEVELOPMENT, INC. (US) 2008-05-22 WO claimed
US-6620572-B1 A heat-sensitive composition of the positive type comprising a polymeric binder and a solubility inhibitor, wherein the said solubility inhibitor consists of an organometallic compound, with the exclusion of the metallocenes, an organic LASTRA S.P.A. (IT) 2003-09-16 US claimed
EP-1072405-B1 Composition sensitive to IR radiation and to heat and lithographic plate coated therewith LASTRA SPA (IT) 2003-06-04 EP claimed
EP-1072405-A1 Composition sensitive to IR radiation and to heat and lithographic plate coated therewith LASTRA S.P.A. (IT) 2001-01-31 EP claimed
US-12589068-B2 Contraceptive medical devices POLY-MED, INC. (US) 2026-03-31 US disclosed
US-20250353748-A1 Three-Dimensional Structured Ferrous Phosphate Pigment with Corrosion Early Warning Capability and Preparation Method Therefor LANXI MAGNESIUM MATERIALS RES INSTITUTE (CN) 2025-11-20 US disclosed
EP-1072405-A1 Composition sensitive to IR radiation and to heat and lithographic plate coated therewith LASTRA S.P.A. (IT) 2001-01-31 EP disclosed
US-6129830-A IN SHORT TIME, USING DEPOSITION BATH CONTAINING COPPER IONS, COMPOUNDS THAT INCREASE ELECTROCONDUCTIVITY OF THE BATH, ADDITIVES TO INFLUENCE MATERIAL PROPERTIES OF THE COPPER, AND COMPOUNDS OF AN ELECTROCHEMICALLY REVERSIBLE REDOX SYSTEM ATOTECH DEUTSCHLAND GMBH (DE) 2000-10-10 US disclosed
WO-2000038657-A1 METHOD FOR PREPARING AN EFFERVESCENT GRANULATE COMPRISING IRON GLUCONATE, GRANULATE THUS OBTAINED AND TABLETS CONTAINING THE SAME E-PHARMA TRENTO S.P.A. (IT) 2000-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12589068-B2 Contraceptive medical devices PGRMC2, PGR, PGRMC1 LMNA 1384/4885PDE4A 1911/4885L3MBTL1 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.